REG — Regis Healthcare Income Statement
0.000.00%
- AU$1.96bn
- AU$1.79bn
- AU$1.10bn
- 89
- 55
- 97
- 92
Annual income statement for Regis Healthcare, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 745 | 753 | 788 | 844 | 1,100 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 661 | 664 | 779 | 842 | 1,048 |
Operating Profit | 83.8 | 88.7 | 9.28 | 2.02 | 51.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.72 | 29.1 | -55.2 | -40.4 | -28.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.716 | 19.9 | -38.8 | -28.5 | -21.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.716 | 19.9 | -38.8 | -28.5 | -21.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.716 | 19.9 | -38.8 | -28.5 | -21.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.031 | 0.021 | -0.076 | -0.104 | -0.088 |
Dividends per Share |